LONDON, March 18, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a real-world study from Spain that showed how a ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence ...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research ...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound ...
ALLEVYN™ LIFE, a silicone foam dressing also indicated for the treatment and prevention of pressure ulcers, developed by Smith & Nephew, was introduced to the protocol as part of the standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results